No Data
Strong Week for Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Doesn't Alleviate Pain of Five-year Loss
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) On The Verge Of Breaking Even
Retail Investors Who Hold 52% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Gained 5.5%, Institutions Profited as Well
Aurinia Pharmaceuticals Up Nearly 14%, on Pace for Largest Percent Increase Since January 2023 -- Data Talk
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options
Insider Purchase: Director at $AUPH (AUPH) Buys 300,000 Shares
